Understanding Depression
Depression is one of the most prevalent mental health conditions in the UK, affecting approximately 3 million people at any given time. While antidepressants and psychological therapies help many patients, up to 30% of people with depression do not respond adequately to first-line treatments — a condition known as treatment-resistant depression (TRD). Medical cannabis is emerging as a clinically supervised option for patients who have exhausted conventional approaches, offering a new pathway to symptom relief.
How Medical Cannabis Can Help
The endocannabinoid system is closely linked to mood regulation, stress response, and neuroplasticity. CBD has demonstrated antidepressant-like effects in preclinical studies, potentially through interactions with serotonin receptors and promotion of neurogenesis in the hippocampus. For patients with depression complicated by chronic pain, insomnia, or anxiety — all common comorbidities — a carefully titrated CBMP can address multiple symptoms simultaneously. MEDCANN's partner clinicians assess each patient holistically before prescribing.
Key Benefits for Depression Patients
- Potential mood improvement and reduced depressive symptoms
- Improved sleep quality — a key driver of mood recovery
- Addresses common comorbidities: anxiety, pain, and insomnia
- Option for patients who cannot tolerate conventional antidepressants
- Regular clinical review to optimise your treatment plan
Am I Eligible?
You may be eligible for medical cannabis for depression if you have a formal diagnosis of depression, have tried at least two conventional treatments (such as SSRIs, SNRIs, or CBT) without adequate benefit, and are a UK resident aged 18 or over. A full clinical assessment including a review of your psychiatric history is conducted at your initial consultation.
Start My Eligibility CheckFrequently Asked Questions
Can medical cannabis be prescribed for depression in the UK?
Yes. Specialist clinicians can prescribe cannabis-based medicinal products (CBMPs) for depression where conventional treatments have not provided adequate relief. This is typically for treatment-resistant cases. MEDCANN works with GMC-registered specialist prescribers.
Is CBD effective for depression?
Preclinical and early clinical evidence suggests CBD has antidepressant-like properties. However, medical cannabis prescribed through MEDCANN is a regulated medicinal product — very different from over-the-counter CBD supplements. Your clinician will determine the appropriate formulation and dose for your specific situation.
Can I take medical cannabis alongside my antidepressants?
Potential drug interactions will be carefully reviewed by your prescribing clinician. Some cannabinoids can interact with antidepressants, particularly SSRIs and MAOIs. A thorough medication review is essential before any prescription is issued.
How do I start treatment for depression at MEDCANN?
Complete our patient registration form online, then book an initial consultation (£200) with one of our specialist clinicians. If appropriate, a prescription will be issued and your medication dispensed and delivered by MEDCANN Pharmacy.
Related Conditions We Treat
Ready to Start Your Treatment Journey?
Book an initial consultation with one of our specialist clinicians. If medical cannabis is appropriate for your depression, a prescription will be issued and your medication dispensed and delivered by MEDCANN Pharmacy.